Read more

April 30, 2021
2 min read
Save

Obesity, OA share 'bidirectional' relationship as drivers of pain, inflammation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Pain in obese individuals with osteoarthritis is caused by biomechanical and inflammatory processes and may involve depression, according to a speaker at the 2021 OARSI World Congress.

Perspective from Brandon J. Erickson, MD

Lisa Carlesso, PT, PhD, assistant professor in the School of Rehabilitation Science at McMaster University, said that obesity and OA have a “bidirectional” relationship. “A key feature of both obesity and OA is pain,” she added.

Obesity_231913452
“There is a need for further elucidation of pathways linking adiposity and its biomarkers to incident or worsening pain,” Lisa Carlesso, PhD, PT, told attendees. Source: Adobe Stock

Digging deeper into these relationships, Carlesso noted that the prevalence of OA effectively doubles in obese individuals compared to non-obese individuals, while obese OA patients have double the risk of chronic pain.

However, Carlesso acknowledged that BMI is flawed as a tool for understanding these relationships. “We know that this is an imperfect measure, as this is a combination of bone, muscle and fat,” she said. “We need to be looking at adiposity and location.”

Lisa Carlesso

That said, Carlesso was clear that weight loss generally improves joint compressive forces. “More is better,” she said. “However, few studies have looked at load changes and how they impact pain.”

Studies to “tease out local inflammatory effects as a function of adipose tissue” would likely move the field closer to a better parameter for describing associations between weight and OA, according to Carlesso.

Adding pain to that equation, Carlesso stressed that it is important for the research and clinical communities to understand which patients are experiencing constant pain and which are experiencing intermittent pain, and why, as a function of obesity and OA. “Inflammation may drive constant pain,” she said.

Zeroing in on adipose tissue as a source of systemic inflammation, the homeostasis between adipocytes and immune cells is critical to normal cytokine production. However, in obese or dysfunctional adipose tissue, interleukin (IL)-4 and IL-10 may be affected, along with immune cells and M1 macrophages.

Adiponectin, leptin and resistin may also be implicated. “The challenge is trying to decipher their relative contribution and associations with pain,” Carlesso said.

If there is an additional component to the equation, it is depression, according to Carlesso. She described psychosocial issues as causing “interplay” between obesity, pain and OA. However, these associations have only been described in small studies. “More work needs to be done in this area to explore these associations,” she said.

Looking ahead, Carlesso called on the research community to conduct longitudinal studies, particularly those looking at gender differences in all the complex associations involving obesity, pain, depression and OA. “There is a need for further elucidation of pathways linking adiposity and its biomarkers to incident or worsening pain,” she said.